Teleflex (TFX) just posted its FY 2025 numbers with Q4 revenue of $401.9 million and EPS of $5.64, alongside trailing 12 month revenue of $2.0 billion and EPS of $1.31 that reflect the full year picture. Over recent quarters, revenue has moved from $764.4 million in Q3 2024 to $700.7 million in Q1 2025, $780.9 million in Q2 2025 and $913.0 million in Q3 2025. Quarterly EPS has ranged from $2.37 in Q3 2024 through $2.08, $2.77 and a loss of $9.24 before rebounding to $5.64 in Q4 2025, leaving investors focused on how these swings flow through to underlying margins and the quality of earnings.

See our full analysis for Teleflex.

With the headline figures on the table, the next step is to see how these results line up against the dominant narratives about Teleflex, highlighting where the story around growth, risks and profitability is reinforced and where it is challenged.

One off items leave trailing margin at 2.9%

• Over the last 12 months, Teleflex generated about US$2.0b of revenue and US$58.5 million of net income from continuing operations, which works out to a 2.9% net margin versus 3.4% the prior year.
• Bulls point to forecast earnings growth of about 39.8% per year as a sign that profitability can scale from this low base, yet the US$173.1 million one off loss in the period means:
  • The trailing 12 month EPS of US$1.31 sits well below the most recent quarterly EPS of US$5.64, so the headline growth story is being judged off numbers that include a sizeable adjustment.
  • Consensus narrative around margin expansion needs to be weighed against the fact that trailing net income from continuing operations is only US$58.5 million on roughly US$2.0b of sales.

High P/E of 93.2x versus both peers and DCF value

• The stock trades on a trailing P/E of 93.2x compared with about 63.8x for peers and 23.6x for the wider US medical equipment industry, while a DCF fair value of US$231.71 sits well above the current share price of US$123.23.
• Supporters of the bullish view argue that strong forecast earnings growth and the gap to the DCF fair value justify this richer multiple, but the data create a mixed picture:
  • The share price is about 46.8% below the DCF fair value, yet the premium P/E means the stock is already priced well above industry and peer averages on current earnings.
  • Analysts also cite earnings growth forecasts of around 39.8% per year, so a key question for bulls is whether that growth materializes fast enough to bring the P/E closer to sector levels.

Bulls argue that the combination of high forecast earnings growth and the current discount to modeled cash flows could set the stage for a rerating if execution stays on track, and you can see how that case is framed in the 🐂 Teleflex Bull Case.

Debt coverage concerns back the cautious view

• Debt is flagged as not well covered by operating cash flow over the last 12 months, at the same time as the company earns a 2.9% net margin and trades on a 93.2x P/E.
• Skeptics highlight this weaker debt coverage and margin profile as key reasons to be cautious, and the recent figures give that stance some support:
  • Trailing 12 month net income from continuing operations of US$58.5 million on roughly US$2.0b of revenue leaves limited room for error if financing costs or one off items rise again.
  • The combination of a high multiple, modest trailing profit and flagged debt coverage risk aligns closely with the bearish narrative that current expectations may be demanding.

If you want to see how those concerns are built into a more cautious scenario, including the earnings and margin paths that skeptics focus on, check the 🐻 Teleflex Bear Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Teleflex on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With mixed signals around growth, valuation, and balance sheet strength, it is worth checking the underlying data yourself and deciding how comfortable you feel with the risk and reward trade off today. To pressure test that view against key red flags and potential upsides, start with the 2 key rewards and 2 important warning signs.

See What Else Is Out There

Teleflex combines a high 93.2x P/E, a thin 2.9% trailing net margin and flagged debt coverage concerns, which leaves limited room for earnings or financing missteps.

If that mix of tight margins and weaker debt coverage feels uncomfortable, it is worth shifting some research time toward companies in the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.